EA201491769A1 - Фармацевтическая композиция с фиксированной дозой, содержащая мометазон и азеластин - Google Patents
Фармацевтическая композиция с фиксированной дозой, содержащая мометазон и азеластинInfo
- Publication number
- EA201491769A1 EA201491769A1 EA201491769A EA201491769A EA201491769A1 EA 201491769 A1 EA201491769 A1 EA 201491769A1 EA 201491769 A EA201491769 A EA 201491769A EA 201491769 A EA201491769 A EA 201491769A EA 201491769 A1 EA201491769 A1 EA 201491769A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pharmaceutical composition
- momethason
- azelastin
- fixed dose
- dose containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Настоящее изобретение относится к фармацевтической композиции с фиксированной дозой, содержащей мометазон и азеластин. В частности, в настоящем изобретении предложены стабильная фармацевтическая композиция с фиксированной дозой в форме назального спрея, содержащая мометазон или его соль и азеластин или его соль, способ получения такой композиции и её применение для лечения ринита у субъекта.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3454MU2012 | 2012-12-06 | ||
BR102013000830A BR102013000830A2 (pt) | 2013-01-11 | 2013-01-11 | Composição farmacêutica para administração nasal, e, uso da mesma |
PCT/IB2013/060638 WO2014087347A1 (en) | 2012-12-06 | 2013-12-04 | Fixed dose pharmaceutical composition comprising mometasone and azelastine |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201491769A1 true EA201491769A1 (ru) | 2015-06-30 |
EA037259B1 EA037259B1 (ru) | 2021-03-01 |
Family
ID=50882873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201491769A EA037259B1 (ru) | 2012-12-06 | 2013-12-04 | Применение фармацевтической композиции с фиксированной дозой, содержащей мометазон и азеластин, для лечения аллергического ринита и способ лечения аллергического ринита |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2928302A1 (ru) |
EA (1) | EA037259B1 (ru) |
MX (2) | MX2014003546A (ru) |
MY (1) | MY196902A (ru) |
PH (1) | PH12015501179A1 (ru) |
WO (1) | WO2014087347A1 (ru) |
ZA (1) | ZA201503799B (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109288790A (zh) * | 2017-07-25 | 2019-02-01 | 健乔信元医药生技股份有限公司 | 鼻用医药组合物及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2389530B (en) * | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
US20070020330A1 (en) * | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
-
2013
- 2013-12-04 WO PCT/IB2013/060638 patent/WO2014087347A1/en active Application Filing
- 2013-12-04 EP EP13861024.1A patent/EP2928302A1/en not_active Withdrawn
- 2013-12-04 MY MYPI2015701670A patent/MY196902A/en unknown
- 2013-12-04 MX MX2014003546A patent/MX2014003546A/es unknown
- 2013-12-04 EA EA201491769A patent/EA037259B1/ru unknown
-
2014
- 2014-03-24 MX MX2019001701A patent/MX2019001701A/es unknown
-
2015
- 2015-05-27 ZA ZA2015/03799A patent/ZA201503799B/en unknown
- 2015-05-27 PH PH12015501179A patent/PH12015501179A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201503799B (en) | 2016-02-24 |
MX2019001701A (es) | 2019-08-14 |
MX2014003546A (es) | 2014-12-09 |
EP2928302A1 (en) | 2015-10-14 |
PH12015501179A1 (en) | 2015-08-17 |
EA037259B1 (ru) | 2021-03-01 |
MY196902A (en) | 2023-05-09 |
WO2014087347A1 (en) | 2014-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
EA201591166A1 (ru) | Ингибиторы аутотаксина | |
EA201690044A1 (ru) | Модуляторы ядерного транспорта и их применение | |
PH12015502615B1 (en) | Chemical compounds | |
EA201492050A1 (ru) | Модуляторы ядерного транспорта и их применение | |
EA201590058A1 (ru) | Аналоги глюкагона | |
EA201492216A1 (ru) | Ингибиторы бромодомена и их применение | |
EA201991484A1 (ru) | Лекарственные формы энзалутамида | |
EA201591727A1 (ru) | Соединения биариламида в качестве ингибиторов киназы | |
EA201500535A1 (ru) | Применение akkermansia muciniphila для лечения метаболических расстройств, увеличения расхода энергии и насыщения, снижения веса, композиция, фармацевтическая композиция, косметическая композиция и лекарственное средство | |
EA201391285A1 (ru) | Производные тетрагидрохинолина, полезные в качестве ингибиторов бромодомена | |
EA201400771A1 (ru) | Новые производные азетидина, фармацевтические композиции и их применение | |
EA201590165A1 (ru) | Сдерживающие злоупотребление фармацевтические композиции для контролируемого высвобождения | |
CL2013003372A1 (es) | Compuestos derivados de espiro-[1,3]-oxacinas y espiro-[1,4]-oxacepinas, inhibidores de bace1 y/o bace2; composicion farmaceutica; procedimiento para prepararlos; y su uso en el tratamiento y/o la profilaxis de la enfermedad de alzheimer y diabetes. | |
EA201391033A1 (ru) | Ингибиторы bace-2 для лечения метаболических расстройств | |
EA201391106A1 (ru) | Новые гетероциклические производные | |
EA201691481A1 (ru) | ИНГИБИТОРЫ C5a ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ПНЕВМОНИИ | |
EA201690039A1 (ru) | Ингибиторы rorc2 и способы их применения | |
CL2014000849A1 (es) | Compuestos derivados de benzilindazoles sustituido, inhibidores de la quinasa bub1; procedimiento de fabricacion; composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento de enfermedades hiperproliferativas. | |
MX2015009444A (es) | Trampas novedosas en el tratamiento de la degeneracion macular. | |
MX2016004741A (es) | Composicion farmaceutica que comprende un antagonista de trpa1 y un agente analgesico. | |
EA201491281A1 (ru) | КОМПОЗИЦИЯ В ФОРМЕ СУХОГО ПОРОШКА, СОДЕРЖАЩАЯ КОРТИКОСТЕРОИД И β-АДРЕНЕРГИЧЕСКОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, ДЛЯ ВВЕДЕНИЯ ИНГАЛЯЦИЕЙ | |
EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
EA201590364A1 (ru) | Применение орвепитанта, его солей и кристаллических форм и композиций, его содержащих, для лечения зуда | |
EA201690783A1 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC4A | Registration of transfer of a eurasian patent by assignment |